Proton Radiotherapy for Recurrent Tumors
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- John Plastaras, MD, PhD
Abramson Cancer Center at Penn Medicine
Principal Investigator - Marcio Fagundes, MD
Procure, Oklahoma City, OK
Principal Investigator - William F. Hartsell, MD
ProCure Proton Therapy Center, Warrenville, IL
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
3 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Procure Proton Therapy Center
Warrenville, Illinois, United States
- Procure
Oklahoma City, Oklahoma, United States
- Abamson Cancer Center of the University of Pennsylvania
Philadelphia, Pennsylvania, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 28 Feb 2010
- Primary completion
- 28 Feb 2017
- Completion
- 30 Apr 2020
- Last update posted
- 24 Apr 2020
- Registered enrollment
- 24
- Registry id
- NCT01126476
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.